| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.54e-06 | 20 | 87 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RANBP2 DENND4A RGPD8 SIPA1L3 RGPD3 ITSN2 ARHGEF26 ARHGAP45 RGPD5 SH3BP4 | 1.25e-05 | 507 | 87 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RANBP2 DENND4A RGPD8 SIPA1L3 RGPD3 ITSN2 ARHGEF26 ARHGAP45 RGPD5 SH3BP4 | 1.25e-05 | 507 | 87 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.78e-05 | 36 | 87 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | histone modifying activity | 6.39e-05 | 229 | 87 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 6.64e-05 | 50 | 87 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 8.36e-05 | 53 | 87 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | neuropilin binding | 1.86e-04 | 5 | 87 | 2 | GO:0038191 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 2.17e-04 | 279 | 87 | 7 | GO:0005096 | |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 2.78e-04 | 6 | 87 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD4 RANBP2 DENND4A PPP4R3C RGPD8 KDM5A SIPA1L3 RGPD3 SERPINF1 ITSN2 APC GRM5 ARHGEF26 ARHGAP45 RGPD5 SH3BP4 | 3.71e-04 | 1418 | 87 | 16 | GO:0030234 |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 5.17e-04 | 8 | 87 | 2 | GO:0032453 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 6.62e-04 | 9 | 87 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | UDP-glucosyltransferase activity | 1.42e-03 | 13 | 87 | 2 | GO:0035251 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.86e-08 | 20 | 88 | 5 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 3.83e-08 | 9 | 88 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 6.37e-08 | 10 | 88 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 2.15e-07 | 13 | 88 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 3.00e-07 | 14 | 88 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 1.04e-05 | 176 | 88 | 7 | GO:0070507 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation involved in prostate gland development | 1.21e-05 | 11 | 88 | 3 | GO:0060768 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in prostate gland development | 1.61e-05 | 12 | 88 | 3 | GO:0060767 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 2.04e-05 | 38 | 88 | 4 | GO:0000413 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 3.62e-05 | 293 | 88 | 8 | GO:0032886 | |
| GeneOntologyBiologicalProcess | mRNA transport | 3.67e-05 | 145 | 88 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | microtubule-based process | HAUS6 EFHC1 DCAF13 ABL1 ATXN7 GTSE1 ASH1L LCA5L NAV3 APC CHMP4BP1 SYBU DNAH7 PLK4 HNRNPU | 3.81e-05 | 1058 | 88 | 15 | GO:0007017 |
| GeneOntologyBiologicalProcess | RNA localization | 3.99e-05 | 217 | 88 | 7 | GO:0006403 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 8.31e-05 | 54 | 88 | 4 | GO:0018208 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 9.26e-05 | 248 | 88 | 7 | GO:0007623 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 9.95e-05 | 108 | 88 | 5 | GO:0031110 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.04e-04 | 175 | 88 | 6 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.04e-04 | 175 | 88 | 6 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.15e-04 | 178 | 88 | 6 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nuclear export | 1.41e-04 | 185 | 88 | 6 | GO:0051168 | |
| GeneOntologyBiologicalProcess | rhythmic process | 1.52e-04 | 360 | 88 | 8 | GO:0048511 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.88e-04 | 195 | 88 | 6 | GO:0006606 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization | 2.16e-04 | 69 | 88 | 4 | GO:0031113 | |
| GeneOntologyBiologicalProcess | import into nucleus | 2.22e-04 | 201 | 88 | 6 | GO:0051170 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | HAUS6 EFHC1 DCAF13 ABL1 ATXN7 NAV3 APC CHMP4BP1 DNAH7 PLK4 HNRNPU | 2.41e-04 | 720 | 88 | 11 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 2.42e-04 | 71 | 88 | 4 | GO:0006111 | |
| GeneOntologyBiologicalProcess | maternal process involved in female pregnancy | 2.69e-04 | 73 | 88 | 4 | GO:0060135 | |
| GeneOntologyBiologicalProcess | learning | 2.95e-04 | 212 | 88 | 6 | GO:0007612 | |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 2.98e-04 | 75 | 88 | 4 | GO:0032922 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell proliferation involved in prostate gland development | 3.73e-04 | 7 | 88 | 2 | GO:0060770 | |
| GeneOntologyBiologicalProcess | mammary gland branching involved in pregnancy | 3.73e-04 | 7 | 88 | 2 | GO:0060745 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 5.68e-04 | 38 | 88 | 3 | GO:0007026 | |
| GeneOntologyBiologicalProcess | gland development | 6.23e-04 | 558 | 88 | 9 | GO:0048732 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 6.77e-04 | 686 | 88 | 10 | GO:0043549 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 6.91e-04 | 249 | 88 | 6 | GO:0015931 | |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 7.64e-04 | 42 | 88 | 3 | GO:0031114 | |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 7.67e-04 | 168 | 88 | 5 | GO:0031109 | |
| GeneOntologyBiologicalProcess | protein O-linked glycosylation via serine | 7.92e-04 | 10 | 88 | 2 | GO:0018242 | |
| GeneOntologyCellularComponent | annulate lamellae | 2.16e-09 | 14 | 87 | 5 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 9.13e-09 | 18 | 87 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear pore | 9.56e-09 | 101 | 87 | 8 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.64e-08 | 20 | 87 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.93e-08 | 8 | 87 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 5.77e-08 | 10 | 87 | 4 | GO:0044614 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.59e-06 | 21 | 87 | 4 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear membrane | 1.48e-05 | 349 | 87 | 9 | GO:0031965 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 RANBP2 ABL1 RGPD8 RGPD3 NAV3 APC CHMP4BP1 NUP42 NUP153 RGPD5 | 2.05e-05 | 560 | 87 | 11 | GO:0005635 |
| GeneOntologyCellularComponent | inclusion body | 3.70e-05 | 90 | 87 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 3.55e-04 | 7 | 87 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | microtubule | 3.74e-04 | 533 | 87 | 9 | GO:0005874 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 4.72e-04 | 8 | 87 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | mitotic spindle microtubule | 1.51e-03 | 14 | 87 | 2 | GO:1990498 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 BPTF RANBP2 RGPD8 ATXN7 RGPD3 SUGP1 KMT2A CHMP4BP1 NUP42 THRAP3 NUP153 HNRNPU RGPD5 | 1.58e-03 | 1377 | 87 | 14 | GO:0140513 |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 2.32e-03 | 133 | 87 | 4 | GO:0005881 | |
| GeneOntologyCellularComponent | organelle envelope | RGPD4 RANBP2 ABL1 RGPD8 RGPD3 NAV3 APC CHMP4BP1 HADHA NUP42 NDUFV1 NUP153 VDAC1 RGPD5 | 2.32e-03 | 1435 | 87 | 14 | GO:0031967 |
| MousePheno | elevated level of mitotic sister chromatid exchange | 9.46e-07 | 16 | 69 | 4 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 7.49e-06 | 26 | 69 | 4 | MP:0012058 | |
| MousePheno | aneuploidy | 1.21e-05 | 61 | 69 | 5 | MP:0004024 | |
| MousePheno | decreased tumor latency | 1.35e-05 | 30 | 69 | 4 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 1.55e-05 | 31 | 69 | 4 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 2.25e-05 | 34 | 69 | 4 | MP:0010307 | |
| MousePheno | abnormal embryo development | RGPD4 BPTF RANBP2 HAUS6 DCAF13 RGPD8 DSP KDM5C UGGT1 RGPD3 SUGP1 APC KMT2A HADHA HUWE1 CPLANE1 PLK4 CEP164 HNRNPU | 2.33e-05 | 1370 | 69 | 19 | MP:0001672 |
| MousePheno | increased hepatocellular carcinoma incidence | 2.39e-05 | 70 | 69 | 5 | MP:0003331 | |
| MousePheno | abnormal chromosome morphology | 3.59e-05 | 126 | 69 | 6 | MP:0003702 | |
| MousePheno | abnormal mitosis | 3.92e-05 | 128 | 69 | 6 | MP:0004046 | |
| MousePheno | abnormal blastocyst formation | 3.92e-05 | 39 | 69 | 4 | MP:0012128 | |
| MousePheno | abnormal chromosome number | 6.46e-05 | 86 | 69 | 5 | MP:0004023 | |
| MousePheno | increased incidence of tumors by chemical induction | 6.73e-05 | 141 | 69 | 6 | MP:0004499 | |
| MousePheno | abnormal endoderm development | 1.43e-04 | 54 | 69 | 4 | MP:0001685 | |
| MousePheno | increased sarcoma incidence | 1.45e-04 | 102 | 69 | 5 | MP:0002032 | |
| MousePheno | abnormal epididymis size | 1.65e-04 | 166 | 69 | 6 | MP:0004926 | |
| MousePheno | increased incidence of induced tumors | 2.07e-04 | 173 | 69 | 6 | MP:0002021 | |
| MousePheno | increased hepatobiliary system tumor incidence | 2.16e-04 | 111 | 69 | 5 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 2.16e-04 | 111 | 69 | 5 | MP:0008019 | |
| MousePheno | abnormal cell nucleus morphology | 2.89e-04 | 184 | 69 | 6 | MP:0003111 | |
| MousePheno | abnormal incidence of induced tumors | 3.52e-04 | 269 | 69 | 7 | MP:0013151 | |
| MousePheno | abnormal epididymis morphology | 3.52e-04 | 269 | 69 | 7 | MP:0002631 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 4.88e-04 | 203 | 69 | 6 | MP:0011094 | |
| MousePheno | increased lung carcinoma incidence | 5.89e-04 | 78 | 69 | 4 | MP:0008714 | |
| MousePheno | abnormal inhibitory learning | 6.60e-04 | 8 | 69 | 2 | MP:0020340 | |
| MousePheno | cognitive inflexibility | 6.60e-04 | 8 | 69 | 2 | MP:0014115 | |
| MousePheno | abnormal germ layer development | 7.16e-04 | 144 | 69 | 5 | MP:0001674 | |
| Domain | Ran_BP1 | 1.42e-09 | 12 | 86 | 5 | PF00638 | |
| Domain | RANBD1 | 1.42e-09 | 12 | 86 | 5 | PS50196 | |
| Domain | RanBD | 2.30e-09 | 13 | 86 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 2.30e-09 | 13 | 86 | 5 | IPR000156 | |
| Domain | PHD | 5.28e-08 | 75 | 86 | 7 | PF00628 | |
| Domain | Znf_PHD-finger | 7.59e-08 | 79 | 86 | 7 | IPR019787 | |
| Domain | Grip | 1.35e-07 | 11 | 86 | 4 | SM00755 | |
| Domain | GRIP | 1.35e-07 | 11 | 86 | 4 | PF01465 | |
| Domain | PHD | 1.74e-07 | 89 | 86 | 7 | SM00249 | |
| Domain | GRIP_dom | 2.02e-07 | 12 | 86 | 4 | IPR000237 | |
| Domain | GRIP | 2.02e-07 | 12 | 86 | 4 | PS50913 | |
| Domain | Znf_PHD | 2.03e-07 | 91 | 86 | 7 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.73e-07 | 95 | 86 | 7 | PS50016 | |
| Domain | ZF_PHD_1 | 2.93e-07 | 96 | 86 | 7 | PS01359 | |
| Domain | Rab_bind | 3.26e-06 | 7 | 86 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 3.26e-06 | 7 | 86 | 3 | IPR032023 | |
| Domain | Znf_FYVE_PHD | 5.18e-06 | 147 | 86 | 7 | IPR011011 | |
| Domain | - | 1.11e-05 | 10 | 86 | 3 | 1.10.220.60 | |
| Domain | Lys_sp_deMease-like_dom | 1.25e-04 | 4 | 86 | 2 | IPR013637 | |
| Domain | PLU-1 | 1.25e-04 | 4 | 86 | 2 | PF08429 | |
| Domain | PH_dom-like | 1.50e-04 | 426 | 86 | 9 | IPR011993 | |
| Domain | HAT_MYST-type | 2.08e-04 | 5 | 86 | 2 | IPR002717 | |
| Domain | zf-C5HC2 | 2.08e-04 | 5 | 86 | 2 | PF02928 | |
| Domain | MOZ_SAS | 2.08e-04 | 5 | 86 | 2 | PF01853 | |
| Domain | Znf_C5HC2 | 2.08e-04 | 5 | 86 | 2 | IPR004198 | |
| Domain | MYST_HAT | 2.08e-04 | 5 | 86 | 2 | PS51726 | |
| Domain | Zinc_finger_PHD-type_CS | 2.29e-04 | 65 | 86 | 4 | IPR019786 | |
| Domain | - | 4.39e-04 | 391 | 86 | 8 | 2.30.29.30 | |
| Domain | TPR-contain_dom | 6.45e-04 | 150 | 86 | 5 | IPR013026 | |
| Domain | BROMODOMAIN_2 | 8.85e-04 | 41 | 86 | 3 | PS50014 | |
| Domain | JmjN | 9.21e-04 | 10 | 86 | 2 | SM00545 | |
| Domain | JmjN | 9.21e-04 | 10 | 86 | 2 | PF02375 | |
| Domain | JMJN | 9.21e-04 | 10 | 86 | 2 | PS51183 | |
| Domain | JmjN | 9.21e-04 | 10 | 86 | 2 | IPR003349 | |
| Domain | Bromodomain | 9.50e-04 | 42 | 86 | 3 | IPR001487 | |
| Domain | BROMO | 9.50e-04 | 42 | 86 | 3 | SM00297 | |
| Domain | - | 9.50e-04 | 42 | 86 | 3 | 1.20.920.10 | |
| Domain | TPR_REGION | 9.91e-04 | 165 | 86 | 5 | PS50293 | |
| Domain | TPR | 9.91e-04 | 165 | 86 | 5 | PS50005 | |
| Domain | H15 | 1.58e-03 | 13 | 86 | 2 | SM00526 | |
| Domain | H15 | 1.58e-03 | 13 | 86 | 2 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 1.84e-03 | 14 | 86 | 2 | IPR005818 | |
| Domain | - | 2.12e-03 | 15 | 86 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 2.12e-03 | 15 | 86 | 2 | SM00501 | |
| Domain | ARID_dom | 2.12e-03 | 15 | 86 | 2 | IPR001606 | |
| Domain | ARID | 2.12e-03 | 15 | 86 | 2 | PS51011 | |
| Domain | ARID | 2.12e-03 | 15 | 86 | 2 | PF01388 | |
| Domain | Post-SET_dom | 2.41e-03 | 16 | 86 | 2 | IPR003616 | |
| Domain | PostSET | 2.41e-03 | 16 | 86 | 2 | SM00508 | |
| Domain | POST_SET | 2.41e-03 | 16 | 86 | 2 | PS50868 | |
| Domain | TPR | 2.98e-03 | 129 | 86 | 4 | SM00028 | |
| Domain | TPR_repeat | 3.33e-03 | 133 | 86 | 4 | IPR019734 | |
| Domain | Semaphorin | 3.77e-03 | 20 | 86 | 2 | IPR027231 | |
| Domain | TPR-like_helical_dom | 4.44e-03 | 233 | 86 | 5 | IPR011990 | |
| Domain | zf-RanBP | 4.56e-03 | 22 | 86 | 2 | PF00641 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.41e-08 | 40 | 71 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 5.15e-08 | 41 | 71 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 5.98e-08 | 42 | 71 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 6.93e-08 | 43 | 71 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.20e-07 | 47 | 71 | 6 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.55e-07 | 49 | 71 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.76e-07 | 50 | 71 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.98e-07 | 51 | 71 | 6 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 3.14e-07 | 55 | 71 | 6 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 4.33e-07 | 58 | 71 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 4.33e-07 | 58 | 71 | 6 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 8.60e-07 | 65 | 71 | 6 | MM15147 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.71e-06 | 18 | 71 | 4 | MM1549 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.72e-06 | 73 | 71 | 6 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 3.41e-06 | 82 | 71 | 6 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 3.93e-06 | 84 | 71 | 6 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 4.51e-06 | 86 | 71 | 6 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 6.67e-06 | 92 | 71 | 6 | MM14951 | |
| Pathway | REACTOME_SUMOYLATION | 2.19e-05 | 169 | 71 | 7 | MM14919 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 2.29e-05 | 114 | 71 | 6 | MM15361 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 6.84e-05 | 202 | 71 | 7 | MM15362 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 7.32e-05 | 277 | 71 | 8 | MM15414 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 RANBP2 ABL1 RGPD8 DSP RGPD3 ITSN2 ARHGEF26 ARHGAP45 PRAG1 AR AKAP12 | 8.65e-05 | 649 | 71 | 12 | MM15690 |
| Pathway | REACTOME_M_PHASE | 1.34e-04 | 387 | 71 | 9 | MM15364 | |
| Pathway | REACTOME_CELL_CYCLE | RGPD4 RANBP2 HAUS6 ABL1 RGPD8 RGPD3 GTSE1 NUP42 PLK4 CEP164 NUP153 | 1.98e-04 | 603 | 71 | 11 | MM14635 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.47e-04 | 175 | 71 | 6 | MM14941 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 4.27e-04 | 272 | 71 | 7 | M29619 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 5.47e-04 | 32 | 71 | 3 | M29579 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 5.99e-04 | 33 | 71 | 3 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 6.55e-04 | 34 | 71 | 3 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 7.14e-04 | 35 | 71 | 3 | M27320 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 7.76e-04 | 36 | 71 | 3 | M27245 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 7.76e-04 | 36 | 71 | 3 | M26974 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 8.41e-04 | 37 | 71 | 3 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 8.41e-04 | 37 | 71 | 3 | M27038 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | RGPD4 RANBP2 DCAF13 RNGTT RGPD8 RGPD3 SUGP1 NUP42 NUP153 HNRNPU | 9.34e-04 | 612 | 71 | 10 | MM15547 |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 9.82e-04 | 39 | 71 | 3 | M27238 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 1.14e-03 | 41 | 71 | 3 | M29574 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.31e-03 | 43 | 71 | 3 | M26975 | |
| Pathway | BIOCARTA_NPC_PATHWAY | 1.34e-03 | 11 | 71 | 2 | M22033 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 1.40e-03 | 44 | 71 | 3 | M109 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.59e-03 | 46 | 71 | 3 | M27397 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.61e-03 | 100 | 71 | 4 | MM14561 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.69e-03 | 47 | 71 | 3 | M27395 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 1.84e-03 | 257 | 71 | 6 | MM14755 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.39e-03 | 53 | 71 | 3 | M27212 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.40e-03 | 271 | 71 | 6 | MM15406 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.53e-03 | 54 | 71 | 3 | M29594 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 2.85e-03 | 117 | 71 | 4 | MM15387 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 3.25e-03 | 59 | 71 | 3 | M27606 | |
| Pubmed | RGPD4 BPTF RANBP2 GGNBP2 DENND4A DCAF13 RGPD8 KDM5A DSP ATXN7 SIPA1L3 UGGT1 RGPD3 ITSN2 ASH1L MARF1 KMT2A HADHA THRAP3 ERICH6 HNRNPU RGPD5 | 7.28e-12 | 1442 | 88 | 22 | 35575683 | |
| Pubmed | 4.22e-11 | 11 | 88 | 5 | 17069463 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.17e-10 | 13 | 88 | 5 | 31427429 | |
| Pubmed | 2.72e-10 | 15 | 88 | 5 | 14697343 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 5.71e-10 | 38 | 88 | 6 | 12791264 | |
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.33e-09 | 7 | 88 | 4 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.33e-09 | 7 | 88 | 4 | 11353387 | |
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 30944974 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.33e-09 | 7 | 88 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.33e-09 | 7 | 88 | 4 | 17372272 | |
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 38657106 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 21205196 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 18949001 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 25187515 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 8603673 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 26632511 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 24403063 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 23818861 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 23536549 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 12191015 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 22821000 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 20682751 | ||
| Pubmed | RGPD4 RANBP2 UBE2O DRG2 RGPD8 KDM5A SIPA1L3 RGPD3 APC HUWE1 GRM5 ARHGEF26 THRAP3 NUP153 AKAP12 HNRNPU | 2.37e-09 | 963 | 88 | 16 | 28671696 | |
| Pubmed | 2.38e-09 | 86 | 88 | 7 | 37253089 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 2.66e-09 | 8 | 88 | 4 | 21670213 | |
| Pubmed | 2.66e-09 | 8 | 88 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 2.66e-09 | 8 | 88 | 4 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 2.66e-09 | 8 | 88 | 4 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 2.66e-09 | 8 | 88 | 4 | 28745977 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND4A ABL1 DRG2 KDM5A DSP SIPA1L3 GTSE1 APC KMT2A PRAG1 MAP3K6 DNAH7 PLK4 ZYX SH3BP4 | 4.22e-09 | 861 | 88 | 15 | 36931259 |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 4.77e-09 | 9 | 88 | 4 | 18394993 | |
| Pubmed | 4.77e-09 | 9 | 88 | 4 | 28100513 | ||
| Pubmed | 4.77e-09 | 9 | 88 | 4 | 17887960 | ||
| Pubmed | 4.77e-09 | 9 | 88 | 4 | 11553612 | ||
| Pubmed | 4.77e-09 | 9 | 88 | 4 | 10601307 | ||
| Pubmed | 4.77e-09 | 9 | 88 | 4 | 9733766 | ||
| Pubmed | 4.77e-09 | 9 | 88 | 4 | 28877029 | ||
| Pubmed | 7.22e-09 | 57 | 88 | 6 | 18022353 | ||
| Pubmed | 7.94e-09 | 10 | 88 | 4 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 7.94e-09 | 10 | 88 | 4 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 7.94e-09 | 10 | 88 | 4 | 8857542 | |
| Pubmed | 7.94e-09 | 10 | 88 | 4 | 21859863 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BPTF RANBP2 KDM5A DSP ATXN7 KDM5C GTSE1 KMT2A HUWE1 KAT6B ZYX THRAP3 NUP153 VDAC1 | 9.15e-09 | 774 | 88 | 14 | 15302935 |
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.25e-08 | 11 | 88 | 4 | 35771867 | |
| Pubmed | 1.25e-08 | 11 | 88 | 4 | 34110283 | ||
| Pubmed | RGPD4 RANBP2 UBE2O RGPD8 DSP RGPD3 CNTNAP2 NAV3 APC HADHA HUWE1 GRM5 THRAP3 NDUFV1 VDAC1 HNRNPU | 2.50e-08 | 1139 | 88 | 16 | 36417873 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 24619213 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BPTF EFNA1 ATXN7 SIPA1L3 KAT6A SEMA3B ASH1L HUWE1 CSMD1 KAT6B ARHGEF26 CHRM3 AR THRAP3 PCDHB16 FRMD3 HNRNPU SH3BP4 | 2.95e-08 | 1489 | 88 | 18 | 28611215 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 RANBP2 HAUS6 RGPD8 SIPA1L3 RGPD3 ITSN2 APC HADHA PLK4 THRAP3 NUP153 AKAP12 VDAC1 HNRNPU RGPD5 | 3.03e-08 | 1155 | 88 | 16 | 20360068 |
| Pubmed | 3.86e-08 | 75 | 88 | 6 | 25593309 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 9480752 | ||
| Pubmed | BPTF RANBP2 UBE2O DCAF13 DSP UGGT1 TUT7 KMT2A HADHA HUWE1 NUP153 VDAC1 | 9.72e-08 | 653 | 88 | 12 | 22586326 | |
| Pubmed | 1.11e-07 | 418 | 88 | 10 | 34709266 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.41e-07 | 232 | 88 | 8 | 25515538 | |
| Pubmed | 2.70e-07 | 22 | 88 | 4 | 27717094 | ||
| Pubmed | 4.42e-07 | 486 | 88 | 10 | 20936779 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RGPD4 RANBP2 RGPD8 DSP SIPA1L3 RGPD3 ITSN2 HADHA THRAP3 HNRNPU RGPD5 | 5.38e-07 | 626 | 88 | 11 | 33644029 |
| Pubmed | 6.03e-07 | 503 | 88 | 10 | 16964243 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RGPD4 RANBP2 DRG2 RGPD8 RGPD3 SUGP1 UMPS HADHA HUWE1 THRAP3 AKAP12 | 9.71e-07 | 665 | 88 | 11 | 30457570 |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 1.28e-06 | 135 | 88 | 6 | 31077711 | |
| Pubmed | 1.30e-06 | 215 | 88 | 7 | 35973513 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RANBP2 HAUS6 DRG2 DSP SIPA1L3 TUT7 GTSE1 ITSN2 APC CPLANE1 DNAH7 CEP164 | 1.63e-06 | 853 | 88 | 12 | 28718761 |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 1.81e-06 | 226 | 88 | 7 | 37839992 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.02e-06 | 146 | 88 | 6 | 23892456 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 2.64e-06 | 153 | 88 | 6 | 26365490 | |
| Pubmed | 3.07e-06 | 157 | 88 | 6 | 30186101 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 3.49e-06 | 477 | 88 | 9 | 31300519 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RANBP2 HAUS6 UBE2O DSP SUGP1 KMT2A PRR14L ZYX NUP153 AKAP12 VDAC1 HNRNPU | 4.14e-06 | 934 | 88 | 12 | 33916271 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | HAUS6 TMPRSS13 DSP UGGT1 APC KMT2A HADHA HUWE1 AKAP12 HNRNPU | 5.09e-06 | 639 | 88 | 10 | 23443559 |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 21705482 | ||
| Pubmed | Ephrin-A1 promotes the malignant progression of intestinal tumors in Apc(min/+) mice. | 6.33e-06 | 2 | 88 | 2 | 18246128 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 39505971 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 18984154 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 24150941 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 7968380 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 32483278 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 27185879 | ||
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 6.35e-06 | 102 | 88 | 5 | 15778465 | |
| Pubmed | 8.12e-06 | 284 | 88 | 7 | 29459677 | ||
| Pubmed | 1.08e-05 | 549 | 88 | 9 | 38280479 | ||
| Pubmed | RANBP2 HAUS6 DSP APC HADHA ARHGEF26 NUP153 AKAP12 VDAC1 HNRNPU | 1.24e-05 | 708 | 88 | 10 | 39231216 | |
| Pubmed | 1.30e-05 | 202 | 88 | 6 | 24639526 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.50e-05 | 724 | 88 | 10 | 36232890 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.58e-05 | 123 | 88 | 5 | 26912792 | |
| Pubmed | 1.62e-05 | 210 | 88 | 6 | 16565220 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 RANBP2 RNGTT RGPD8 DSP UGGT1 RGPD3 UMPS HADHA HUWE1 VDAC1 HNRNPU RGPD5 | 1.64e-05 | 1257 | 88 | 13 | 37317656 |
| Pubmed | 1.73e-05 | 20 | 88 | 3 | 23637629 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 25238203 | ||
| Pubmed | RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. | 1.90e-05 | 3 | 88 | 2 | 17320161 | |
| Pubmed | Heterogeneous susceptibility of circulating SIV isolate capsids to HIV-interacting factors. | 1.90e-05 | 3 | 88 | 2 | 23883001 | |
| Pubmed | KDM5 family of demethylases promotes CD44-mediated chemoresistance in pancreatic adenocarcinomas. | 1.90e-05 | 3 | 88 | 2 | 37880235 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 23906303 | ||
| Pubmed | E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling. | 1.90e-05 | 3 | 88 | 2 | 28137882 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 23063713 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 38230606 | ||
| Pubmed | MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain. | 1.90e-05 | 3 | 88 | 2 | 36754959 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 30811977 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 11856748 | ||
| Interaction | RAN interactions | RGPD4 RANBP2 UBE2O ABL1 RNGTT RGPD8 DSP UGGT1 RGPD3 ASH1L KMT2A NUP42 AR NUP153 HNRNPU RGPD5 | 1.80e-10 | 475 | 87 | 16 | int:RAN |
| Interaction | NUP43 interactions | MSRB3 BPTF RANBP2 RGPD8 KDM5A DSP KDM5C ASH1L MARF1 MUC19 APC KMT2A NUP42 NUP153 VDAC1 RGPD5 | 9.30e-09 | 625 | 87 | 16 | int:NUP43 |
| Interaction | RGPD4 interactions | 3.32e-08 | 22 | 87 | 5 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 1.00e-07 | 27 | 87 | 5 | int:RGPD2 | |
| Interaction | RGPD8 interactions | 7.96e-07 | 74 | 87 | 6 | int:RGPD8 | |
| Interaction | NPIPB6 interactions | 9.47e-07 | 18 | 87 | 4 | int:NPIPB6 | |
| Interaction | RGPD3 interactions | 1.78e-06 | 47 | 87 | 5 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 2.19e-06 | 49 | 87 | 5 | int:RGPD1 | |
| Interaction | RANBP2 interactions | RGPD4 RANBP2 RGPD8 RGPD3 CNTNAP2 SUGP1 APC HUWE1 NUP153 RGPD5 | 3.53e-06 | 361 | 87 | 10 | int:RANBP2 |
| Interaction | RGPD5 interactions | 3.69e-06 | 96 | 87 | 6 | int:RGPD5 | |
| Interaction | C11orf58 interactions | 4.96e-06 | 101 | 87 | 6 | int:C11orf58 | |
| Interaction | TNPO1 interactions | 6.93e-06 | 306 | 87 | 9 | int:TNPO1 | |
| Interaction | NXF2 interactions | 8.99e-06 | 65 | 87 | 5 | int:NXF2 | |
| Interaction | NUP50 interactions | 1.65e-05 | 341 | 87 | 9 | int:NUP50 | |
| Interaction | IER2 interactions | 1.92e-05 | 37 | 87 | 4 | int:IER2 | |
| Interaction | MYCBP2 interactions | 2.26e-05 | 355 | 87 | 9 | int:MYCBP2 | |
| Interaction | CIBAR1 interactions | 2.84e-05 | 137 | 87 | 6 | int:CIBAR1 | |
| Interaction | SNRNP200 interactions | 2.90e-05 | 460 | 87 | 10 | int:SNRNP200 | |
| Interaction | FBXW11 interactions | RANBP2 GGNBP2 APC SYBU HUWE1 MAP3K6 PLK4 THRAP3 NUP153 HNRNPU | 3.67e-05 | 473 | 87 | 10 | int:FBXW11 |
| Interaction | NUP153 interactions | 4.17e-05 | 216 | 87 | 7 | int:NUP153 | |
| Interaction | RNF31 interactions | 6.06e-05 | 403 | 87 | 9 | int:RNF31 | |
| Interaction | SASS6 interactions | 6.54e-05 | 159 | 87 | 6 | int:SASS6 | |
| Interaction | YWHAH interactions | DENND4A ABL1 DRG2 KDM5A DSP SIPA1L3 GTSE1 APC KMT2A HUWE1 PRAG1 MAP3K6 DNAH7 PLK4 SH3BP4 | 6.86e-05 | 1102 | 87 | 15 | int:YWHAH |
| Interaction | NR3C1 interactions | FAT4 GGNBP2 KDM5A DSP ATXN7 ITSN2 SUGP1 HADHA ARHGAP45 DNAH7 AR NUP153 VDAC1 HNRNPU | 6.93e-05 | 974 | 87 | 14 | int:NR3C1 |
| Interaction | KPNA2 interactions | 7.97e-05 | 519 | 87 | 10 | int:KPNA2 | |
| Interaction | MKRN1 interactions | 8.03e-05 | 165 | 87 | 6 | int:MKRN1 | |
| Interaction | CCDC92 interactions | 8.07e-05 | 53 | 87 | 4 | int:CCDC92 | |
| Interaction | SIRT7 interactions | BPTF RANBP2 UBE2O DCAF13 DSP UGGT1 TUT7 KMT2A HADHA HUWE1 NUP153 VDAC1 | 8.22e-05 | 744 | 87 | 12 | int:SIRT7 |
| Interaction | MORF4L2 interactions | 8.87e-05 | 168 | 87 | 6 | int:MORF4L2 | |
| Interaction | RPS19 interactions | BPTF RANBP2 UBE2O DCAF13 KAT6A ASH1L SUGP1 HADHA HUWE1 THRAP3 HNRNPU | 9.40e-05 | 639 | 87 | 11 | int:RPS19 |
| Interaction | KPNA3 interactions | 9.93e-05 | 248 | 87 | 7 | int:KPNA3 | |
| Interaction | MRGBP interactions | 1.10e-04 | 109 | 87 | 5 | int:MRGBP | |
| Interaction | LINC01588 interactions | 1.13e-04 | 22 | 87 | 3 | int:LINC01588 | |
| Interaction | KPNB1 interactions | RANBP2 RNGTT RGPD8 HADHA NUP42 HUWE1 THRAP3 NUP153 VDAC1 HNRNPU | 1.17e-04 | 544 | 87 | 10 | int:KPNB1 |
| Interaction | PHF21A interactions | 1.18e-04 | 343 | 87 | 8 | int:PHF21A | |
| Interaction | H3C1 interactions | BPTF FAT4 KDM5A DSP KAT6A ASH1L NAV3 KMT2A PRR14L HADHA KAT6B THRAP3 HNRNPU | 1.25e-04 | 901 | 87 | 13 | int:H3C1 |
| Interaction | CEP152 interactions | 1.26e-04 | 179 | 87 | 6 | int:CEP152 | |
| Interaction | EED interactions | BPTF RANBP2 DCAF13 DRG2 KDM5A DSP SFTPD UGGT1 ITSN2 UMPS HADHA HUWE1 AR THRAP3 VDAC1 HNRNPU SH3BP4 | 1.29e-04 | 1445 | 87 | 17 | int:EED |
| Interaction | CIT interactions | MSRB3 BPTF RANBP2 HAUS6 DCAF13 DSP RGPD3 ASH1L KMT2A PRR14L HADHA NUP42 ZYX THRAP3 NUP153 VDAC1 HNRNPU | 1.34e-04 | 1450 | 87 | 17 | int:CIT |
| Interaction | ATXN1 interactions | RANBP2 FAT4 GGNBP2 DRG2 KAT6A SUGP1 UMPS HADHA SYBU HUWE1 AR ZYX THRAP3 AKAP12 | 1.37e-04 | 1039 | 87 | 14 | int:ATXN1 |
| Interaction | BTF3 interactions | RGPD4 RANBP2 RGPD8 DSP SIPA1L3 RGPD3 ITSN2 HADHA THRAP3 CEP164 HNRNPU RGPD5 | 1.60e-04 | 799 | 87 | 12 | int:BTF3 |
| Interaction | ENTR1 interactions | 1.64e-04 | 188 | 87 | 6 | int:ENTR1 | |
| Interaction | PSMD7 interactions | 1.68e-04 | 270 | 87 | 7 | int:PSMD7 | |
| Interaction | TPR interactions | 2.15e-04 | 281 | 87 | 7 | int:TPR | |
| Interaction | TNRC6B interactions | 2.19e-04 | 282 | 87 | 7 | int:TNRC6B | |
| Interaction | DCAF4 interactions | 2.29e-04 | 378 | 87 | 8 | int:DCAF4 | |
| Interaction | ALDH16A1 interactions | 2.39e-04 | 70 | 87 | 4 | int:ALDH16A1 | |
| Interaction | C19orf53 interactions | 2.62e-04 | 29 | 87 | 3 | int:C19orf53 | |
| Interaction | GRWD1 interactions | 2.82e-04 | 390 | 87 | 8 | int:GRWD1 | |
| Interaction | YWHAE interactions | DENND4A UBE2O ABL1 SIPA1L3 GTSE1 APC KMT2A HUWE1 ARHGAP45 PRAG1 PLK4 ZYX VDAC1 HNRNPU SH3BP4 | 2.89e-04 | 1256 | 87 | 15 | int:YWHAE |
| Interaction | TELO2 interactions | 2.98e-04 | 135 | 87 | 5 | int:TELO2 | |
| Interaction | GUSBP5 interactions | 3.12e-04 | 75 | 87 | 4 | int:GUSBP5 | |
| Interaction | ESRP1 interactions | 3.45e-04 | 77 | 87 | 4 | int:ESRP1 | |
| Interaction | SOX2 interactions | BPTF RANBP2 RNGTT DSP SIPA1L3 TUT7 SERPINF1 SEMA3B MARF1 NAV3 KMT2A HADHA KAT6B CPLANE1 THRAP3 HNRNPU | 3.46e-04 | 1422 | 87 | 16 | int:SOX2 |
| Interaction | ACTR3 interactions | 3.53e-04 | 305 | 87 | 7 | int:ACTR3 | |
| Interaction | LZTS2 interactions | 3.64e-04 | 512 | 87 | 9 | int:LZTS2 | |
| Interaction | SIRT6 interactions | 3.72e-04 | 628 | 87 | 10 | int:SIRT6 | |
| Interaction | MAPRE1 interactions | 3.74e-04 | 514 | 87 | 9 | int:MAPRE1 | |
| Interaction | DDB2 interactions | 3.88e-04 | 143 | 87 | 5 | int:DDB2 | |
| Interaction | NUP107 interactions | 3.92e-04 | 221 | 87 | 6 | int:NUP107 | |
| Interaction | PRKCZ interactions | 4.07e-04 | 412 | 87 | 8 | int:PRKCZ | |
| Interaction | SH3GL3 interactions | 4.14e-04 | 145 | 87 | 5 | int:SH3GL3 | |
| Interaction | COL17A1 interactions | 4.22e-04 | 34 | 87 | 3 | int:COL17A1 | |
| Interaction | SMU1 interactions | 4.52e-04 | 227 | 87 | 6 | int:SMU1 | |
| Interaction | KRT18 interactions | 4.55e-04 | 419 | 87 | 8 | int:KRT18 | |
| Interaction | MAPRE3 interactions | 4.84e-04 | 230 | 87 | 6 | int:MAPRE3 | |
| Interaction | HSP90B1 interactions | UBE2O EFNA1 SIPA1L3 UGGT1 KMT2A HADHA HUWE1 NDUFV1 VDAC1 HNRNPU | 4.87e-04 | 650 | 87 | 10 | int:HSP90B1 |
| Interaction | RNPS1 interactions | 5.00e-04 | 425 | 87 | 8 | int:RNPS1 | |
| Interaction | RMC1 interactions | 5.13e-04 | 152 | 87 | 5 | int:RMC1 | |
| Interaction | UBXN6 interactions | 5.15e-04 | 325 | 87 | 7 | int:UBXN6 | |
| Interaction | KIF20A interactions | MSRB3 RGPD4 RANBP2 RGPD8 TMPRSS13 DSP RGPD3 LCA5L NAV3 HADHA THRAP3 VDAC1 HNRNPU | 5.58e-04 | 1052 | 87 | 13 | int:KIF20A |
| Cytoband | 2q13 | 3.12e-04 | 68 | 88 | 3 | 2q13 | |
| Cytoband | 2q12.3 | 4.85e-04 | 17 | 88 | 2 | 2q12.3 | |
| Cytoband | 12q14.3 | 6.75e-04 | 20 | 88 | 2 | 12q14.3 | |
| Cytoband | 11q23 | 2.19e-03 | 36 | 88 | 2 | 11q23 | |
| GeneFamily | PHD finger proteins | 2.10e-08 | 90 | 61 | 7 | 88 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.27e-05 | 115 | 61 | 5 | 769 | |
| GeneFamily | AT-rich interaction domain containing | 1.14e-03 | 15 | 61 | 2 | 418 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 1.30e-03 | 16 | 61 | 2 | 66 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.47e-03 | 17 | 61 | 2 | 486 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 2.05e-03 | 20 | 61 | 2 | 736 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 2.26e-03 | 21 | 61 | 2 | 89 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 2.95e-03 | 24 | 61 | 2 | 485 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.25e-03 | 181 | 61 | 4 | 694 | |
| GeneFamily | Nucleoporins | 5.20e-03 | 32 | 61 | 2 | 1051 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.86e-03 | 34 | 61 | 2 | 487 | |
| GeneFamily | EF-hand domain containing | 6.38e-03 | 219 | 61 | 4 | 863 | |
| Coexpression | BIDUS_METASTASIS_UP | 5.31e-08 | 221 | 87 | 9 | M15866 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BPTF RANBP2 HAUS6 GGNBP2 DENND4A KDM5A ATXN7 ITSN2 KAT6A ASH1L KMT2A HUWE1 KAT6B ARHGAP45 ZYX THRAP3 NUP153 HNRNPU | 1.60e-06 | 1492 | 87 | 18 | M40023 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 4.30e-06 | 33 | 87 | 4 | MM477 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP | 4.73e-06 | 200 | 87 | 7 | M4016 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 7.16e-06 | 300 | 87 | 8 | M8702 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 1.27e-05 | 43 | 87 | 4 | MM3857 | |
| Coexpression | LEE_NEURAL_CREST_STEM_CELL_DN | 5.48e-05 | 122 | 87 | 5 | M10276 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.35e-05 | 229 | 87 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 4.38e-05 | 407 | 87 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.04e-06 | 168 | 88 | 6 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.12e-06 | 170 | 88 | 6 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.16e-06 | 171 | 88 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-06 | 176 | 88 | 6 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.51e-06 | 179 | 88 | 6 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 184 | 88 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.33e-06 | 193 | 88 | 6 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.33e-06 | 193 | 88 | 6 | b38aaffbea36ef6c08ebe82675438f873c89b242 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.33e-06 | 193 | 88 | 6 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.33e-06 | 193 | 88 | 6 | de569c6e507856fd3ac2311f246cb597074ed30c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.40e-06 | 194 | 88 | 6 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | 11.5-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 2.55e-06 | 196 | 88 | 6 | 2648d64b0e7b59ae78182d55f32699ceea37ff8d | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.70e-06 | 198 | 88 | 6 | 1eb49b853a9e144e840c660060473fc7873f6478 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.70e-06 | 198 | 88 | 6 | 9a12e5e47236433e512c668005fe3f8be6fde95c | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Late_airway_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.78e-06 | 199 | 88 | 6 | 494461665f945ce6c97299c58f7785e90dec5812 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.26e-06 | 131 | 88 | 5 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.95e-06 | 141 | 88 | 5 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.58e-06 | 143 | 88 | 5 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.91e-06 | 144 | 88 | 5 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 1.46e-05 | 156 | 88 | 5 | 63b8cf14361b282872bc1c5b65d9fbc83e81a089 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.60e-05 | 159 | 88 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.03e-05 | 167 | 88 | 5 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.15e-05 | 169 | 88 | 5 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.40e-05 | 173 | 88 | 5 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.61e-05 | 176 | 88 | 5 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.14e-05 | 183 | 88 | 5 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 184 | 88 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.22e-05 | 184 | 88 | 5 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 184 | 88 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 184 | 88 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.57e-05 | 188 | 88 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 188 | 88 | 5 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | ASK428-Endothelial-Lymphatic|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.57e-05 | 188 | 88 | 5 | c371bc340966cfe9205cbf4b62c6452f49f2559f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-05 | 189 | 88 | 5 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-05 | 190 | 88 | 5 | e102622f05c7f3e1bd8b224ea159d57033793ee0 | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.76e-05 | 190 | 88 | 5 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.76e-05 | 190 | 88 | 5 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.76e-05 | 190 | 88 | 5 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-05 | 191 | 88 | 5 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.95e-05 | 192 | 88 | 5 | be5e246b2350398b985767b2fbede17a8dd8cc44 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 3.95e-05 | 192 | 88 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.95e-05 | 192 | 88 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 194 | 88 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.15e-05 | 194 | 88 | 5 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.15e-05 | 194 | 88 | 5 | ea5b7727ffef6cb454c501979a51bc1d4108d0e4 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.25e-05 | 195 | 88 | 5 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | 11.5-Airway-Epithelial-Secretory_progenitor|Airway / Age, Tissue, Lineage and Cell class | 4.25e-05 | 195 | 88 | 5 | 8cbc78a6cb812f907c69b00f85263976216840ac | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.25e-05 | 195 | 88 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.36e-05 | 196 | 88 | 5 | b6226163d9fc93ecfff2115bb74408303a000490 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.36e-05 | 196 | 88 | 5 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.36e-05 | 196 | 88 | 5 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.46e-05 | 197 | 88 | 5 | 4ae08ccb6f1da626c4f0fb0140a2811cb6e31ba1 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.46e-05 | 197 | 88 | 5 | 8f009a15f154b3bb184b489da4722b7c27de7e11 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.57e-05 | 198 | 88 | 5 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.57e-05 | 198 | 88 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.57e-05 | 198 | 88 | 5 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | ASK428-Endothelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.57e-05 | 198 | 88 | 5 | d69d0ff115298596173a4278897a65007a71f5df | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.57e-05 | 198 | 88 | 5 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | Biopsy_IPF-Epithelial-SCGB3A2+|Biopsy_IPF / Sample group, Lineage and Cell type | 4.79e-05 | 200 | 88 | 5 | 2aaf130d702d18c277d16b6800f006a53ed653fb | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-05 | 200 | 88 | 5 | c59f262b2b0a7e7dcb2940d1e466f98db6c56625 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.79e-05 | 200 | 88 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-05 | 200 | 88 | 5 | e50ef394e3284a8323bfd60575b262b2be422aea | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.40e-04 | 133 | 88 | 4 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | Control-NK|World / Disease group and Cell class | 1.85e-04 | 143 | 88 | 4 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 2.01e-04 | 146 | 88 | 4 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | ASK454-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.17e-04 | 149 | 88 | 4 | 078792d5272f1881757dc47daa96e87449cf5d34 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.17e-04 | 149 | 88 | 4 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | MS-CD4-CD8_1|MS / Condition, Cell_class and T cell subcluster | 2.23e-04 | 150 | 88 | 4 | 7dc95c58b98d8c4c6c49fb1a03ec6ac24fb41f54 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.28e-04 | 151 | 88 | 4 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 2.34e-04 | 152 | 88 | 4 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-3|ILC / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-04 | 61 | 88 | 3 | d0b33a48ee2faf68b270f9279c630437f3e8b20b | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.52e-04 | 155 | 88 | 4 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-04 | 156 | 88 | 4 | 547e2debfc09c07c049a880dded5fda7dd53e156 | |
| ToppCell | 18-Distal-Epithelial-Basal_cell|Distal / Age, Tissue, Lineage and Cell class | 2.71e-04 | 158 | 88 | 4 | 183f445967e09e871c93d8e94781ed9fec894169 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.78e-04 | 159 | 88 | 4 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-04 | 161 | 88 | 4 | 4f25eeabb841b0b9204cdd4e71d5e131e7868184 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.98e-04 | 162 | 88 | 4 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.98e-04 | 162 | 88 | 4 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.98e-04 | 162 | 88 | 4 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-04 | 163 | 88 | 4 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-04 | 163 | 88 | 4 | 2d6fd2562d78be9f83fa35d811eb7e27eb8cc5d1 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.13e-04 | 164 | 88 | 4 | fe11fcce4ba7f44ba2989ea3705916b67e75f8e7 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.13e-04 | 164 | 88 | 4 | b6beb8548ac0dd07e8a580a938e5ee4bf25a3c1f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-04 | 164 | 88 | 4 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, Lineage and Cell Type | 3.20e-04 | 165 | 88 | 4 | 8728f927502e56f2768b4224e9111939d3d7815a | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.27e-04 | 166 | 88 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 167 | 88 | 4 | b4ef07117d14da3d5fbced949e4dfcb01c392295 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 167 | 88 | 4 | 94fc7df7ca55cd722a8dbd153201a29891217473 | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.35e-04 | 167 | 88 | 4 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-04 | 167 | 88 | 4 | a90f905ef38437752e2b0b71bd0322a184de1861 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 167 | 88 | 4 | eff3723fe60755272eca237459165e436e919ece | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.43e-04 | 168 | 88 | 4 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 3.43e-04 | 168 | 88 | 4 | cfed36fece51871a5abbcde71f6bd5e7212357ff | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-04 | 168 | 88 | 4 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-04 | 168 | 88 | 4 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 3.50e-04 | 169 | 88 | 4 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-04 | 169 | 88 | 4 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-04 | 169 | 88 | 4 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-04 | 169 | 88 | 4 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.66e-04 | 171 | 88 | 4 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| Drug | Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 6.75e-07 | 190 | 87 | 8 | 4114_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 7.03e-07 | 191 | 87 | 8 | 4283_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 5.89e-06 | 180 | 87 | 7 | 4541_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 8.99e-06 | 192 | 87 | 7 | 4104_DN | |
| Drug | Terazosin hydrochloride [63590-64-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 9.30e-06 | 193 | 87 | 7 | 7187_UP | |
| Drug | Prednicarbate [73771-04-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | 9.30e-06 | 193 | 87 | 7 | 5119_DN | |
| Drug | Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HG-U133A | 9.94e-06 | 195 | 87 | 7 | 1886_DN | |
| Drug | Glibenclamide [10238-21-8]; Up 200; 8uM; PC3; HT_HG-U133A | 1.03e-05 | 196 | 87 | 7 | 5849_UP | |
| Drug | Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.10e-05 | 198 | 87 | 7 | 7416_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.10e-05 | 198 | 87 | 7 | 1073_DN | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A | 1.10e-05 | 198 | 87 | 7 | 4550_DN | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.10e-05 | 198 | 87 | 7 | 6239_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; PC3; HT_HG-U133A | 1.13e-05 | 199 | 87 | 7 | 3994_DN | |
| Drug | Eburnamonine (-) [4880-88-0]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.13e-05 | 199 | 87 | 7 | 2781_DN | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.13e-05 | 199 | 87 | 7 | 6675_DN | |
| Drug | Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; PC3; HT_HG-U133A | 1.13e-05 | 199 | 87 | 7 | 4555_DN | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; PC3; HT_HG-U133A | 1.17e-05 | 200 | 87 | 7 | 4618_DN | |
| Drug | AC1L9ASI | 3.53e-05 | 17 | 87 | 3 | CID000441230 | |
| Drug | Y 290 | 4.22e-05 | 18 | 87 | 3 | CID000114729 | |
| Drug | benzoyl-S-CoA | 7.21e-05 | 58 | 87 | 4 | CID000122174 | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 8.74e-05 | 189 | 87 | 6 | 3788_DN | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 9.26e-05 | 191 | 87 | 6 | 4969_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 9.26e-05 | 191 | 87 | 6 | 6020_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 3606_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 4559_DN | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 7413_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 3354_DN | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 7538_DN | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 6667_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 2621_UP | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 3431_DN | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; MCF7; HT_HG-U133A | 1.04e-04 | 195 | 87 | 6 | 3459_DN | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.04e-04 | 195 | 87 | 6 | 4399_DN | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A | 1.04e-04 | 195 | 87 | 6 | 6648_DN | |
| Drug | Ramipril [87333-19-5]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.04e-04 | 195 | 87 | 6 | 7144_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 4291_UP | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 3199_DN | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 3206_DN | |
| Drug | Antimycin A [1397-94-0]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 2098_UP | |
| Drug | felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.07e-04 | 196 | 87 | 6 | 848_DN | |
| Drug | Pyrithyldione [77-04-3]; Down 200; 24uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 3482_DN | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 3767_DN | |
| Drug | Pirenperone [ 75444-65-4]; Up 200; 10.2uM; HL60; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 2455_UP | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 5244_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 3995_DN | |
| Drug | Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 5087_DN | |
| Drug | Bufexamac [2438-72-4]; Down 200; 18uM; PC3; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 5090_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 1485_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 6934_DN | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 1504_DN | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; HL60; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 2356_DN | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 3175_DN | |
| Drug | Moricizine hydrochloride [31883-05-3]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 3520_DN | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 2256_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 7557_DN | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; MCF7; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 6491_DN | |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 5804_DN | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 1493_DN | |
| Drug | patuletin | 1.43e-04 | 5 | 87 | 2 | CID005281678 | |
| Drug | testosterone hemisuccinate | 2.14e-04 | 6 | 87 | 2 | CID000119202 | |
| Drug | Bortezomib | HAUS6 DENND4A DCAF13 ABL1 DNAJC14 KDM5C KMT2A HADHA KAT6B AR VDAC1 | 3.44e-04 | 838 | 87 | 11 | ctd:D000069286 |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.74e-04 | 160 | 87 | 5 | 5275_UP | |
| Drug | AC1LCVO8 | 3.98e-04 | 8 | 87 | 2 | CID000656891 | |
| Drug | 1-isocyanopropane | 4.46e-04 | 39 | 87 | 3 | CID000079084 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.93e-04 | 170 | 87 | 5 | 3791_DN | |
| Drug | ampicillinoic acid | 5.55e-04 | 42 | 87 | 3 | CID006453491 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.78e-04 | 176 | 87 | 5 | 1212_DN | |
| Drug | toltrazuril | 6.37e-04 | 10 | 87 | 2 | CID000068591 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.39e-04 | 180 | 87 | 5 | 1793_DN | |
| Drug | 12 p | 6.43e-04 | 274 | 87 | 6 | CID000081248 | |
| Drug | Lynestrenol [52-76-6]; Up 200; 14uM; MCF7; HT_HG-U133A | 6.56e-04 | 181 | 87 | 5 | 1537_UP | |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; MCF7; HT_HG-U133A | 6.72e-04 | 182 | 87 | 5 | 4376_DN | |
| Drug | adefovir dipivoxil | 6.84e-04 | 104 | 87 | 4 | ctd:C106812 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 7.06e-04 | 184 | 87 | 5 | 2321_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 7.24e-04 | 185 | 87 | 5 | 1114_DN | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 7.41e-04 | 186 | 87 | 5 | 3518_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 7.41e-04 | 186 | 87 | 5 | 5000_DN | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 7.59e-04 | 187 | 87 | 5 | 1070_UP | |
| Drug | homatropin | 7.76e-04 | 11 | 87 | 2 | CID000003623 | |
| Drug | C04424 | 7.76e-04 | 11 | 87 | 2 | CID011953835 | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 7.78e-04 | 188 | 87 | 5 | 6735_DN | |
| Drug | Isotretinoin [4759-48-2]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 7.97e-04 | 189 | 87 | 5 | 7438_UP | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 7.97e-04 | 189 | 87 | 5 | 1206_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 7.97e-04 | 189 | 87 | 5 | 6649_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 8.16e-04 | 190 | 87 | 5 | 4507_DN | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 8.16e-04 | 190 | 87 | 5 | 4155_UP | |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 8.16e-04 | 190 | 87 | 5 | 3253_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 8.16e-04 | 190 | 87 | 5 | 4322_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 8.16e-04 | 190 | 87 | 5 | 2869_DN | |
| Drug | pyrvinium pamoate; Down 200; 1.25uM; MCF7; HT_HG-U133A_EA | 8.16e-04 | 190 | 87 | 5 | 870_DN | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 8.16e-04 | 190 | 87 | 5 | 2299_DN | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 8.35e-04 | 191 | 87 | 5 | 2850_DN | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A | 8.35e-04 | 191 | 87 | 5 | 6644_DN | |
| Drug | Piperine [94-62-2]; Down 200; 14uM; PC3; HT_HG-U133A | 8.35e-04 | 191 | 87 | 5 | 4247_DN | |
| Drug | monastrol; Up 200; 20uM; MCF7; HG-U133A | 8.35e-04 | 191 | 87 | 5 | 614_UP | |
| Drug | Fenbendazole [43210-67-9]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 8.35e-04 | 191 | 87 | 5 | 3888_DN | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 8.55e-04 | 192 | 87 | 5 | 4110_DN | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A | 8.55e-04 | 192 | 87 | 5 | 4496_DN | |
| Drug | Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; PC3; HT_HG-U133A | 8.55e-04 | 192 | 87 | 5 | 6639_DN | |
| Drug | Piperacetazine [3819-00-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 8.55e-04 | 192 | 87 | 5 | 7191_UP | |
| Disease | Malignant neoplasm of breast | SEMA3A EFNA1 ABL1 ITSN2 ELAPOR1 GSDMB UMPS KAT6B MAP3K6 GALNT16 AR AKAP12 | 3.55e-05 | 1074 | 81 | 12 | C0006142 |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 4.45e-05 | 4 | 81 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | leiomyoma (is_implicated_in) | 1.11e-04 | 6 | 81 | 2 | DOID:127 (is_implicated_in) | |
| Disease | Hereditary Diffuse Gastric Cancer | 1.58e-04 | 293 | 81 | 6 | C1708349 | |
| Disease | Intellectual Disability | 2.31e-04 | 447 | 81 | 7 | C3714756 | |
| Disease | Epilepsy | 2.36e-04 | 109 | 81 | 4 | C0014544 | |
| Disease | Prostatic Neoplasms | 2.91e-04 | 616 | 81 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.91e-04 | 616 | 81 | 8 | C0376358 | |
| Disease | Carcinoma, Granular Cell | 2.99e-04 | 116 | 81 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.99e-04 | 116 | 81 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.99e-04 | 116 | 81 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.99e-04 | 116 | 81 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.99e-04 | 116 | 81 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 2.99e-04 | 116 | 81 | 4 | C0001418 | |
| Disease | neutrophil count | DENND4A EFHC1 ATXN7 KDM5C ITSN2 ASH1L ELAPOR1 GSDMB UNC13C ARHGAP45 GALNT16 AKAP12 | 3.77e-04 | 1382 | 81 | 12 | EFO_0004833 |
| Disease | Liver carcinoma | 4.93e-04 | 507 | 81 | 7 | C2239176 | |
| Disease | amino acid measurement | 5.49e-04 | 678 | 81 | 8 | EFO_0005134 | |
| Disease | Mammary Carcinoma, Human | 6.06e-04 | 525 | 81 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 6.06e-04 | 525 | 81 | 7 | C1257931 | |
| Disease | schizophrenia, sex interaction measurement | 6.09e-04 | 60 | 81 | 3 | EFO_0008343, MONDO_0005090 | |
| Disease | Mammary Neoplasms | 6.20e-04 | 527 | 81 | 7 | C1458155 | |
| Disease | wellbeing measurement | 6.27e-04 | 692 | 81 | 8 | EFO_0007869 | |
| Disease | Breast Carcinoma | 7.00e-04 | 538 | 81 | 7 | C0678222 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 8.28e-04 | 152 | 81 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Parkinson's disease (is_marker_for) | 8.41e-04 | 67 | 81 | 3 | DOID:14330 (is_marker_for) | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 8.71e-04 | 16 | 81 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | colorectal cancer (is_marker_for) | 9.34e-04 | 157 | 81 | 4 | DOID:9256 (is_marker_for) | |
| Disease | neuroimaging measurement, brain volume measurement | 1.16e-03 | 286 | 81 | 5 | EFO_0004346, EFO_0006930 | |
| Disease | susceptibility to mumps measurement | 1.17e-03 | 75 | 81 | 3 | EFO_0008404 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.17e-03 | 75 | 81 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Stomach Neoplasms | 1.37e-03 | 297 | 81 | 5 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.43e-03 | 300 | 81 | 5 | C0024623 | |
| Disease | Epilepsy, Cryptogenic | 1.51e-03 | 82 | 81 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 1.51e-03 | 82 | 81 | 3 | C0751111 | |
| Disease | Aura | 1.51e-03 | 82 | 81 | 3 | C0236018 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 1.51e-03 | 21 | 81 | 2 | C1292769 | |
| Disease | non-alcoholic fatty liver disease | 1.61e-03 | 182 | 81 | 4 | EFO_0003095 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.62e-03 | 84 | 81 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | sensory peripheral neuropathy, remission | 1.81e-03 | 23 | 81 | 2 | EFO_0009785, MONDO_0002321 | |
| Disease | response to radiation, Hematuria | 1.81e-03 | 23 | 81 | 2 | GO_0009314, HP_0000790 | |
| Disease | FEV/FEC ratio | 1.93e-03 | 1228 | 81 | 10 | EFO_0004713 | |
| Disease | Neurodevelopmental Disorders | 2.16e-03 | 93 | 81 | 3 | C1535926 | |
| Disease | reticulocyte measurement | 2.37e-03 | 1053 | 81 | 9 | EFO_0010700 | |
| Disease | blood manganese measurement | 2.50e-03 | 27 | 81 | 2 | EFO_0007581 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 2.74e-03 | 101 | 81 | 3 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLTFDSSFSPNTGKK | 96 | P21796 | |
| KHGSKFLTSFPDGTT | 431 | Q7L0X2 | |
| SSGRKKLTDSPGLFS | 1621 | Q9NR48 | |
| DGKDSSSRPLGTFTK | 1161 | Q96PZ7 | |
| SPVTSETGSTFKKFF | 286 | Q02952 | |
| GKTKSFPEEKDGASS | 226 | Q8TAX9 | |
| FSVHVKDGGSFPKTD | 2536 | Q6V0I7 | |
| KDGGSFPKTDSTTVT | 2541 | Q6V0I7 | |
| QKSVDDGGSFPKSFS | 411 | P20309 | |
| VVSGFDFDSPTSSKK | 321 | Q96DR7 | |
| STAISKPVGFGEKSD | 106 | P59074 | |
| FKSEKSNGELSESPG | 751 | Q12830 | |
| SPTGKEFVSASFDKS | 291 | Q9NV06 | |
| TGTPSKGFDEKAYLS | 61 | Q8N428 | |
| SKFALPGKSEVTSSF | 1416 | Q7Z401 | |
| FGTSETSKAPKSGFE | 1586 | P49792 | |
| ASSETSKAPKSGFEG | 1646 | P49792 | |
| SSEKSKPFAFGNSSA | 2526 | P49792 | |
| SEKSKPFVFGNSSAT | 1551 | Q99666 | |
| SEKSKPFAFGNSSAT | 1551 | O14715 | |
| PKDQESFGSASKSGA | 1036 | Q9NZM3 | |
| TKGLIDGLTKFFTPS | 431 | Q8WYB5 | |
| SLKFPSDFSRVSSGK | 176 | Q6Y2X3 | |
| DGSSSSFRSKKPIVG | 131 | P41594 | |
| GAGDFKKFERTSSSG | 636 | Q92619 | |
| GKKESEPGSSASFGK | 206 | O60942 | |
| TETLFGPDSGKGAKS | 611 | Q9H3C7 | |
| KSFTSKRTPDGFDSV | 986 | Q6UXG2 | |
| TFSGLLKISDFGTSK | 781 | O95382 | |
| SYGSSSSGDLDRKKP | 41 | Q7Z5P9 | |
| SSGDSDRTKPFFSLG | 96 | Q7Z5P9 | |
| FYGSSSSGDSDKKKP | 141 | Q7Z5P9 | |
| IGRSTATSSFGFKKP | 1056 | Q8IVL0 | |
| ATSSFGFKKPSGVGS | 1061 | Q8IVL0 | |
| KEAAGKSSGPTSLFA | 181 | Q00839 | |
| DSGYEPSFGKSSRIK | 571 | O95447 | |
| KSTEDTAEYSPFKGG | 301 | P10275 | |
| PGTFGSLSKGIKDTF | 191 | Q8N8V4 | |
| PAKVSDGGSSSTDFK | 3556 | Q7Z6Z7 | |
| FSFFPSLSKSKGGSA | 186 | O15265 | |
| FKIPKFSIGDSPDSS | 451 | Q9NYZ3 | |
| ADISSKDFGSGFPVK | 411 | P29375 | |
| GKPEVTSAASFSFKS | 291 | O15504 | |
| VDSPKRTSSGDFKFS | 761 | Q6ZMV5 | |
| TGGSETSEFKFLKPI | 756 | Q9NRJ7 | |
| TKGLIDGLTKFFTPS | 406 | Q92794 | |
| SSEKSKPFAFGNSSA | 1551 | A6NKT7 | |
| PCKDSTGTTTFLGFT | 226 | A2A2Y4 | |
| KLSTSGIPEKFHGTD | 101 | Q86V35 | |
| FSSGPEFKKTLASKT | 2746 | Q9H799 | |
| FTPFTLGKEFKEGHS | 111 | P20827 | |
| KAITGFDDPFSGKTV | 2091 | P15924 | |
| DDSYVGPSTSKSKGK | 101 | Q8WXX0 | |
| QFDSSTFGGHKSEKP | 746 | P00519 | |
| TSLGKAASKFGSPEV | 326 | Q9Y4F3 | |
| ASGSPFKSVTLEDGK | 466 | Q16798 | |
| VDPKKLDSLTTSFGF | 566 | P40939 | |
| FLPGTSFKDSTKTAF | 11 | Q5JVL4 | |
| TESSAFGGSLPAKKS | 516 | Q7Z4H7 | |
| SGLYFSTKGTSKEPR | 261 | Q14449 | |
| GEEDIPFYSSSTGKK | 2641 | Q03164 | |
| FSGKPSSSSRKNFKG | 321 | Q9UHC6 | |
| STSRYKPGTGSFSKD | 436 | Q86VF2 | |
| KTGDKGFSSTFTGER | 61 | Q96EY8 | |
| SEFGKESTFGISSKE | 1206 | Q5THK1 | |
| SSEKSKPFAFGNSSA | 1551 | Q7Z3J3 | |
| ELPGKSTFFGTSDEF | 81 | Q9Y5W9 | |
| KSDAPTSSSFFTGLK | 256 | Q9P0V3 | |
| SGDTTAPKKTSFGSL | 21 | P49821 | |
| GSGFPEKKSTISASE | 1606 | O60292 | |
| CPSKTFGGFDSTKDL | 381 | Q14563 | |
| LLEPSKSASSKGEGF | 41 | P55039 | |
| TPLFKSETKFDSGSG | 91 | Q8IXL7 | |
| PKNKSSTDFSSSGDG | 326 | O00444 | |
| AVEFSSGAKSPSKSG | 1351 | P25054 | |
| GGSPTKKAVTFDLSD | 1211 | Q9UPV0 | |
| FRKAKASSTGSFTAP | 316 | Q8IWZ8 | |
| KGDFPTGKSSFSITR | 551 | Q9Y2W1 | |
| TGFGKTRETDDKTSP | 451 | Q9BYE2 | |
| DLSDKTFSFPKFGST | 786 | Q8NB66 | |
| SLFDSPDFSKITGKP | 336 | P36955 | |
| STSLGKGSFLDKISP | 506 | Q9BW04 | |
| TDSKTEGKFTYPTGE | 316 | P35247 | |
| KSGLVKPGSEADFSS | 136 | Q9NX95 | |
| PSKTFGTFSSTKDFP | 381 | Q13214 | |
| KPGVTFTSAKGEVFS | 916 | Q9C0C9 | |
| FKFGDFVLKSGLSSP | 21 | P11172 | |
| TTLSASGTGFGDKFK | 706 | P49790 | |
| SAKPGTKSGFKGFDT | 876 | P49790 | |
| IGDFKFGVSSESKPE | 956 | P49790 | |
| KEELPKSSSAGFSFG | 1011 | P49790 | |
| FSSSDPLEKAFKGSG | 876 | Q86YV5 | |
| DTSGNKFTSSPGEKV | 56 | Q6UW63 | |
| DDISVGFTSKGLSPK | 56 | Q86XU0 | |
| FSSKSSTKPAAGGTA | 181 | Q15942 | |
| DFPGTKLSLFGSSKN | 1036 | Q5VYS8 | |
| SFTSDNSFAKGPIAK | 1046 | Q9NYU2 | |
| SKEFGSGFPVSDSKR | 446 | P41229 |